Role of Comorbidity in Mortality Related to Staphylococcus aureus Bacteremia: A Prospective Study Using the Charlson Weighted Index of Comorbidity
Authors:
- Pierre MeyerPMPierre Meyer
- 1 December 2003
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 24 (12) , 890-896
Abstract
Objective: To demonstrate the effectiveness of the Charlson weighted index of comorbidity (WIC) for controlling comorbidity in prospective studies focusing on mortality in patients with Staphylococcus aureus bacteremia (SAB).Design: Cohort study.Setting: Two tertiary-care, university-affiliated hospitals in France.Patients: One hundred sixty-six inpatients 18 years or older consecutively diagnosed with SAB from May 15, 2001, to May 15, 2002.Methods: Patients were prospectively assessed and cases were followed by the infectious diseases consult service at least 3 months after effective antibiotic therapy completion. The Charlson WIC was computed and dichotomized into scores of fewer than 3 points and 3 or more points. Bacteremia source, acute complication due to SAB acquisition in the ICU, and inappropriate empiric antibiotic therapy were recorded. The endpoint was death due to SAB and overall mortality.Results: In univariate analysis, the Charlson WIC was able to predict overall mortality and S. aureus-related death. The following variables were found to be independently predictive of mortality due to SAB using the Cox model: an acute complication due to S. aureus (OR, 8.9; CI95, 4 to 19.7; P < .001), a Charlson WIC score of 3 or more (OR, 3; CI95, 1.3 to 5.5; P = .006), and age (OR, 1.04; CI95, 1.009 to 1.07; P < .01).Conclusions: Comorbidity contributes to death in patients with SAB. The Charlson WIC is a good predictor of mortality in this population and may be a useful instrument to control comorbidity in studies aiming to investigate risk factors for death due to bacteremia.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2000
- Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort StudyInfection Control & Hospital Epidemiology, 1999
- The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in AdultsClinical Infectious Diseases, 1997
- MRSA bacteraemiaJournal of Hospital Infection, 1997
- Course and Outcome of Bacteremia Due to Staphylococcus aureus: Evaluation of Different Clinical Case DefinitionsClinical Infectious Diseases, 1993
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- Prospective Study of 114 Consecutive Episodes of Staphylococcus aureus BacteremiaClinical Infectious Diseases, 1987
- Staphylococcus aureus bacteremia caused by infected intravenous cathetersAmerican Journal of Infection Control, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987